Literature DB >> 17918225

Management of penile cancer.

Antonio Augusto Ornellas.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 17918225     DOI： 10.1002/jso.20893

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  7 in total

Review 1.  Contemporary management of patients with penile cancer and lymph node metastasis.

Authors:  Andrew Leone; Gregory J Diorio; Curtis Pettaway; Viraj Master; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

Review 2.  Penile cancer: current therapy and future directions.

Authors:  G Sonpavde; L C Pagliaro; C Buonerba; T B Dorff; R J Lee; G Di Lorenzo
Journal:  Ann Oncol       Date:  2013-01-04       Impact factor: 32.976

3.  Long-term outcomes for penile cancer patients presenting with advanced N3 disease requiring a myocutaneous flap reconstruction or primary closure-a retrospective single centre study.

Authors:  Hussain M Alnajjar; Findlay MacAskill; Michelle Christodoulidou; Ash Mosahebi; Clare Akers; Raj Nigam; Peter Malone; David Ralph; Anita Mitra; Asif Muneer
Journal:  Transl Androl Urol       Date:  2019-03

Review 4.  The burden of HPV-associated anogenital cancers.

Authors:  Katie Wakeham; Kimberley Kavanagh
Journal:  Curr Oncol Rep       Date:  2014-09       Impact factor: 5.945

5.  Surgical treatment of advanced penile cancer.

Authors:  Ke Zhang; Xiang Wan; Huan Xu; Wenzhi Li; Juan Zhou; Ming-Xi Xu; Hai-Jun Yao; Zhong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-10       Impact factor: 4.553

Review 6.  An update on treatment of penile cancer.

Authors:  Juskaran Chadha; Jad Chahoud; Philippe E Spiess
Journal:  Ther Adv Med Oncol       Date:  2022-09-24       Impact factor: 5.485

7.  Competing-risks model for predicting the prognosis of penile cancer based on the SEER database.

Authors:  Jin Yang; Zhenyu Pan; Yujing He; Fanfan Zhao; Xiaojie Feng; Qingqing Liu; Jun Lyu
Journal:  Cancer Med       Date:  2019-10-27       Impact factor: 4.452
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.